FindTrial
Sign In

Sevoflurane or propofol anaesthesia for coronary artery patients in non-cardiac surgery

Sevoflurane or propofol anaesthesia for coronary artery patients in non-cardiac surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001671
Enrollment
Unknown
Registered
2011-10-30
Start date
2007-03-04
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery patients in non-cardiac surgery

Interventions

sevoflurane group:sevoflurane 1.0–2.0 MAC and remifentanil (0.5–1.0 mg/kg.h)
propofol group:propofol 2–4 mg kg-1 h-1 and remifentanil (0.5–1.0 mg/kg.h)

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
42 Years to 83 Years

Inclusion criteria

Inclusion criteria: patients with coronary artery disease in non-cardiac surgery

Exclusion criteria

Exclusion criteria: Acute cardiac failure, unstable angina, recent (6 months) myocardial infarction or coronary intervention (PCI), emergency surgery, combined or re-do procedures, and participation in another study that might interfere with the endpoints of the current trial.

Design outcomes

Primary

MeasureTime frame
cTn;—

Countries

China

Contacts

Public ContactShanglong Yao
yao_shanglong@yahoo.com.cn+86 027 85351618

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026